MRI

The Diagnostic Imaging MRI modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of MRI across the healthcare continuum, including breast, neurological, cardiovascular, prostate imaging, and more.

Latest News

MRI Study Reveals Early Differences in Mild Cognitive Impairment Preceding Alzheimer’s Disease and Parkinson’s Disease

By Jeff Hall

January 21st 2025

For patients with mild cognitive impairment (MCI), early changes with respect to decreased intra-network connectivity involving the default mode network or salience network may aid in differentiating between the development of Alzheimer’s disease and Parkinson’s disease, according to new MRI research.

Seven Takeaways from New CT and MRI Guidelines for Ovarian Cancer Staging

By Jeff Hall

January 20th 2025

FDA Clears Brain MRI-Based Software for Assessing Cortical Disarray Measurement

By Jeff Hall

January 16th 2025

Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?

By Jeff Hall

January 14th 2025

Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?

By Jeff Hall

January 13th 2025

Latest CME Events & Activities

Annual Hawaii Cancer Conference

January 25-26, 2025

21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®

February 8, 2025

Community Practice Connections™: The 2nd Annual Hawaii Lung Cancers Conference®

18th Annual New York GU Cancers Congress™

March 28-29, 2025

Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®

Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?

Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?

26th Annual International Lung Cancer Congress®

July 25-26, 2025

2025 International Symposium of Gastrointestinal Oncology (ISGIO)

September 12-13, 2025

Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection

(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure

(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure